CME Group (CME) Tops Q2 EPS by 3c

CME Group (NASDAQ: CME) reported Q2 EPS of $1.64, $0.03 better than the analyst estimate of $1.61. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.18 billion.

"As economies continued to recover during the first half of the year, trading increased across a majority of our asset classes," said CME Group Chairman and Chief Executive Officer Terry Duffy. "Average daily volume grew by 5% during Q2, led by double-digit, year-over-year increases in our Interest Rates, Agricultural and Options markets. We also introduced several innovative new products, including a new suite of micro-sized contracts that allow market users to customize their trading and hedging, as well as new ESG-focused futures contracts that help manage climate-related risk. Looking ahead, we will continue to support our clients\' evolving trading needs through additional product innovation and the upcoming launch of our joint venture company to provide post-trade services for OTC markets."

For earnings history and earnings-related data on CME Group (CME) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• Akari Therapeutics adds oncology expert Patricia LoRusso to advisory board
• ADNOC Distribution agrees to buy Shell's South Africa unit for $1B